Health Care & Life Sciences » Biotechnology | Acceleron Pharma Inc.

Acceleron Pharma Inc.

Acceleron Pharma Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$2.2 B
Shares Outstanding
52.69 M
Public Float
43.08 M


128 Sidney Street
Cambridge Massachusetts 02139
United States
Employees -
Updated 07/08/2019
Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L.


View All

Habib J. Dable
President, Chief Executive Officer & Director
Francois Nader
Non-Executive Chairman